Faisal Ghiath Sukhtian - Net Worth and Insider Trading
Faisal Ghiath Sukhtian Net Worth
The estimated net worth of Faisal Ghiath Sukhtian is at least $20,400 dollars as of 2024-09-20. Faisal Ghiath Sukhtian is the Director of Outlook Therapeutics Inc and owns about 3,400 shares of Outlook Therapeutics Inc (OTLK) stock worth over $20,400. Details can be seen in Faisal Ghiath Sukhtian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Faisal Ghiath Sukhtian has not made any transactions after 2022-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Faisal Ghiath Sukhtian
Faisal Ghiath Sukhtian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Faisal Ghiath Sukhtian owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Faisal Ghiath Sukhtian’s form 4 insider trades.
Insider Ownership Summary of Faisal Ghiath Sukhtian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2022-10-07 | director |
Faisal Ghiath Sukhtian Latest Holdings Summary
Faisal Ghiath Sukhtian currently owns a total of 1 stock. Faisal Ghiath Sukhtian owns 3,400 shares of Outlook Therapeutics Inc (OTLK) as of October 7, 2022, with a value of $20,400.
Latest Holdings of Faisal Ghiath Sukhtian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2022-10-07 | 3,400 | 6.00 | 20,400 |
Holding Weightings of Faisal Ghiath Sukhtian
Faisal Ghiath Sukhtian Form 4 Trading Tracker
According to the SEC Form 4 filings, Faisal Ghiath Sukhtian has made a total of 4 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 1,500 shares on October 7, 2022, which cost Faisal Ghiath Sukhtian around $38,700.
Insider Trading History of Faisal Ghiath Sukhtian
- 1
Faisal Ghiath Sukhtian Trading Performance
GuruFocus tracks the stock performance after each of Faisal Ghiath Sukhtian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Faisal Ghiath Sukhtian is 35.25%. GuruFocus also compares Faisal Ghiath Sukhtian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Faisal Ghiath Sukhtian within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Faisal Ghiath Sukhtian's insider trading performs compared to the benchmark.
Performance of Faisal Ghiath Sukhtian
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.31 | | | | | |
| Relative Return to S&P 500(%) | 8.47 | | | | | |
Faisal Ghiath Sukhtian Ownership Network
Faisal Ghiath Sukhtian Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Faisal Ghiath Sukhtian is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Faisal Ghiath Sukhtian made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 520,000 shares made by Terry Dagnon , a net purchase of 62,484 shares made by Jeff Evanson , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,000 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 20,994 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Faisal Ghiath Sukhtian Mailing Address
Above is the net worth, insider trading, and ownership report for Faisal Ghiath Sukhtian. You might contact Faisal Ghiath Sukhtian via mailing address: 7th Circle, Zahran St., Zahran Plaza Bldg,4th Flr, Po Box 142909, Amman M2 11844.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
